ETF I have been accumulating to benefit from bear market – series #1: $COWZ
Woah - we are in deep bear market. The indices are down, but I can also tell from some of these nasty bear market rallies (or squeezes) - these bear…
$XBI is no longer a good way to have exposure / to hedge biotech – single stock picking / shorting is more important than ever
We are all aware of how bad $xbi (biotech ETF) has been over the past year. $XBI is flat over the past three years, down -30% over the past year,…
Lesson from PM: Stick to you pre-set process
When we think about great investors, we tend to think of them as people who have great experience and move significant amount of capital on gut feeling that theoretically comes…
Screening for good ideas as a hedge fund analyst – case study with Novo Nordisk – assess the set-up relative to fundamentals
I recently started looking into Novo Nordisk - studying fundamentals and building out financial models. It is a European diversitfied pharma company that owns a leading position in global diabetes…